Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens

Diagnostic Microbiology and Infectious Disease

Volumn 71, Issue 3, 2011, Pages 279-285

  Meira, Cristina S ^a   Vidal, José E ^b   Costa Silva, Thaís A ^a   Frazatti Gallina, Neuza ^c   Pereira Chioccola, Vera L ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

Author keywords

Cerebral toxoplasmosis diagnosis; ESA proteins; HIV infected patients; Toxoplasma gondii

Indexed keywords

ANTIBODY; EXCRETORY SECRETORY ANTIBODY; EXCRETORY SECRETORY ANTIGEN; PARASITE ANTIGEN; TACHYZOITE ANTIGEN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANTIBODY DETECTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; SERODIAGNOSIS; SEROLOGY; STATISTICAL ANALYSIS; STUDENT T TEST; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; MALE; TOXOPLASMA; TOXOPLASMOSIS, CEREBRAL; YOUNG ADULT;

EID: 80053911051     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.07.008     Document Type: Article

References (48)

1. Alfonso Y., Fraga J., Fonseca C., Jiménez N., Pinillos T., Dorta-Contreras A.J., Cox R., Capó V., Pomier O., Bandera F., Ginorio D. Molecular diagnosis of Toxoplasma gondii infection in cerebrospinal fluid from AIDS patients. Cerebrospinal. Fluid Res. 2009, 6:2.
2. Ammassari A., Cingolani A., Pezzotti P., De Luca A., Murri R., Giancola M.L., et al. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000, 55:1194-1200.
3. Antinori A., Larussa D., Cingolani A., Lorenzini P., Bossolasco S., Finazzi M.G., et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. HIV/AIDS 2004, 39:1681-1691.
4. Bastien P. Molecular diagnosis of toxoplasmosis. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:S205-S215.
5. Beaman M.H., Luft B.J., Remington J.S. Prophylaxis for toxoplasmosis in AIDS. Ann. Intern. Med. 1992, 117:163-164.
6. Borges A.S., Figueiredo J.F. Evaluation of intrathecal synthesis of specific IgG antibodies against Toxoplasma gondii in the diagnosis assessment of presumptive toxoplasma encephalitis in AIDS patients. Rev. Soc. Bras. Med. Trop. 2004, 6:480-484.
7. Burg J.L., Grove C.M., Pouletty P., Boothroyd J.C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 1989, 27:1787-1792.
8. Carruthers V.B. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Trop. 2002, 81:111-122.
9. Cérède O., Dubremetz J.F., Soête M., Deslée D., Vial H., Bout D., Lebrun M. Synergistic role of micronemal proteins in Toxoplasma gondii virulence. J. Exp. Med. 2005, 201:453-463.
10. Cesbron-Delauw M.F., Capron A. Excreted-secreted antigens of Toxoplasma gondii: their origin and role in the host-parasite interaction. Res. Immunol. 1993, 144:41-44.
11. Collazos J. Opportunistic infections of the CNS in patients with AIDS. CNS. Drugs. 2003, 17:869-887.
12. Colombo F.A., Vidal J.E., Penalva de Oliveira A.C., Hernández A.V., Bonasser-Filho F., Nogueira R.S., Focaccia R., Pereira-Chioccola V.L. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J. Clin. Microbiol. 2005, 43:5044-5047.
13. Contini C. Clinical and diagnostic management of toxoplasmosis in the immunocompromised patient. Parasitol 2008, 50:45-50.
14. Costa-Silva T.A., Meira C.S., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii. Exp. Parasitol. 2008, 120:227-234.
15. Costa-Silva T.A., Meira C.S., Frazzati-Gallina N., Pereira-Chioccola V.L. Toxoplasma gondii tachyzoites: production in Vero cell cultures that do not require the addition of fetal calf serum. Exp. Parasitol. 2011, In press.
16. Dannemann B., McCutchan J.A., Israelski D., Antoniskis D., Leport C., Luft B., Nussbaum J., Clumeck N., Morlat P., Chiu J. Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann. Interm. Med. 1992, 116:33-43.
17. Darcy F., Foudrinier F., Mougeot G., Decoster A., Caron A., Marx-Chemla C., Capron A., Pinon J.M. Diagnostic value of specific IgA antibodies in AIDS patients with Toxoplasma infection: a bicentric evaluation. Immunol. Lett. 1991, 30:345-348.
18. Derouin F., Leport C., Pueyo S., Morlat P., Letrillart B., Chene G., Ecobichon J.L., Luft B., Aubertin J., Hafner R., Vilde J.L., Salamon R. Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS 1996, 10:1521-1527.
19. Dubey J.P. Toxoplasma gondii. Medical microbiology 1996, The University of Texas. http://www.ncbi.nlm.nih.gov/books/NBK7752/, 4th ed. S. Baron, R.C. Peake, D.A. James, M. Susman, C.A. Kennedy, M.J.D. Singleton, S. Schuenke (Eds.).
20. Dubey J.P., Lindsay D.S., Speer C.A. Structure of Toxoplasma gondii tachyzoites, bradyzoites and sporozoites and biology and development of tissue cyst. Clin. Microbiol. Rev. 1998, 2:267-299.
21. Duquesne V., Auriault C., Darcy F., Decavel J.P., Capron A. Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T-cells. Infect. Immun. 1990, 58:2120-2126.
22. Fachado A., Fonte L., Alberti E., Hadad P., Fonseca L., Machin R., Finlay C. Usefulness of the detection of Toxoplasma gondii antigens in AIDS patients. Rev. Inst. Med. Trop. 1994, 36:525-529.
23. Ge Y.Y., Zhang L., Zhang G., Wu J.P., Tan M.J., Hu E., Liang Y.J., Wang Y. In pregnant mice, the infection of Toxoplasma gondii causes the decrease of CD4+CD25+-regulatory T cells. Parasite Immunol. 2008, 30:471-481.
24. Hellerbrand C., Goebel F.D., Disko R. High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 1996, 15:869-872.
25. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 2002, 8:634-640.
26. Hill D.E., Chirukandoth S., Dubey J.P. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim. Health Res. Rev. 2005, 6:41-61.
27. Luft B.J., Chua A. Central nervous system toxoplasmosis in HIV: pathogenesis, diagnosis, and therapy. Curr. Infect. Dis. Rep. 2000, 2:358-362.
28. Luft B.J., Remington J.S. Toxoplasmic encephalitis. Clin. Infect. Dis. 1992, 15:211-222.
29. Luft B.J., Brooks R.G., Conley F.K., McCabe R.E., Remington J.S. Toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome. JAMA 1984, 252:913-917.
30. Luft B.J., Hafner R., Korzun A.H., Leport C., Antoniskis D., Bosler E.M., Bourland D.D., Uttamchandani R., Fuhrer J., Jacobson J., et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1993, 329:995-1000.
31. Mechain B., Garin Y.J., Robert-Gangneux F., Dupouy-Camet J., Derouin F. Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients. Clin. Diagn. Lab. Immunol. 2000, 7:703-705.
32. Meira C.S., Costa-Silva T.A., Vidal J.E., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients. J. Med. Microbiol. 2008, 57:845-850.
33. Mattos C.C.B., Meira C.S., Ferreira A.I.C., Frederico F.B., Hiramoto R.M., Almeida G.C., Mattos L.C., Pereira-Chioccolab V.L. Contribution of laboratory methods in diagnosing clinically suspected ocular toxoplasmosis in Brazilian patients. Diag. Microbiol. Infec. Dis. 2011, 70:362-366.
34. Mesquita R.T., Vidal J.E., Pereira-Chioccola V.L. Molecular diagnosis of cerebral toxoplasmosis: comparing markers that determine Toxoplasma gondii by PCR in peripheral blood from HIV-infected patients. Braz. J. Infect. Dis. 2010, 14:346-350.
35. Mesquita R.T., Ziegler A.P., Hiramoto R.M., Vidal J.E., Pereira-Chioccola V.L. Real-time quantitative PCR in cerebral toxoplasmosis diagnosis of Brazilian human immunodeficiency virus-infected patients. J. Med. Microbiol. 2010, 59:641-647.
36. Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J. Trop. Med. Public Health 2009, 40:1158-1178.
37. Oksenhendler E., Charreau I., Tournerie C., Azihary M., Carbon C., Aboulker J.P. Toxoplasma gondii infection in advanced HIV infection. AIDS 1994, 8:483-487.
38. Patel B., Young Y., Duffy K., Tanner R.P., Johnson J., Holliman R.E. Immunoglobulin-A detection and the investigation of clinical toxoplasmosis. J. Med. Microbiol. 1993, 28:286-292.
39. Pereira-Chioccola V.L., Vidal J.E., Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiol. 2009, 4:1363-1379.
40. Portegies P., Solod L., Cinque P., Chaudhuri A., Begovac J., Everall I., Weber T., Bojar M., Martinez-Martin P., Kennedy G.E. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur. J. Neurol. 2004, 11:297-304.
41. Potasman I., Resnick L., Luft B.J., Remington J.S. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1988, 108:49-51.
42. Prigione I., Fachetti P., Lecordier L., Deslée D., Chiesa S., Delawn M.F.C., et al. T cell clones raised from chronically infected healthy humans by stimulation with Toxoplasma gondii excretory-secretory antigens cross-react with live tachyzoites: characterization of fine antigens specificity of the clones and implication for vaccine development. J. Immunol. 2000, 164:741-3748.
43. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly antiretroviral therapy. J. Neurovirol. 2002, 8:115-121.
44. Tilley M., Fichera M.E., Jerome M.E., Roos D.S., White M.W. Toxoplasma gondii sporozoites from a transient parasitophorus vacuole that is impermeable and contains only a subset of dense granule proteins. Infect. Immunol. 1997, 65:4598-4605.
45. Tuazon C.U.J. Toxoplasmosis in AIDS patients. Antimicrob. Chemother. 1989, 23:77-82.
46. Vidal J.E., Colombo F.A., Penalva de Oliveira A.C., Focaccia R., Pereira-Chioccola V.L. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J. Clin. Microbiol. 2004, 42:4765-4768.
47. Vidal J.E., Hernandez A.V., Penalva de Oliveira A.C., Dauar R., Barboza S.P., Focaccia R. Cerebral toxoplasmosis in HIV-Positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS 2005, 19:840-848.
48. Wainstein M.V., Wolffenbuttel L., Lopes D.K., González H.E., Golbspan L., Ferreira L., Sprinz E., Kronfeld M., Edelweiss M.I. Sensibilidade e especificidade do diagnóstico clínico, sorológico e tomográfico da encefalite por Toxoplasma gondii na síndrome da imunodeficiência adquirida. Rev. Soc. Bras. Med. Trop. 1993, 26:71-75.